Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration.
about
Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectinDo nutritional supplements have a role in age macular degeneration prevention?A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degenerationThe potential role of amyloid beta in the pathogenesis of age-related macular degeneration.Therapeutic targets in age-related macular diseaseCirculating anti-retinal antibodies as immune markers in age-related macular degenerationAmyloidosis in Retinal Neurodegenerative DiseasesInflammation and its role in age-related macular degenerationDementia of the eye: the role of amyloid beta in retinal degenerationGenetics of immunological and inflammatory components in age-related macular degenerationNLRP3 inflammasome: activation and regulation in age-related macular degenerationThe proteomics of drusenAt the interface of sensory and motor dysfunctions and Alzheimer's disease.Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degenerationBeta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD)Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse modelThe Eye As a Biomarker for Alzheimer's DiseaseAmyloid properties of the leader peptide of variant B cystatin C: implications for Alzheimer and macular degenerationNLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen componentsAge-related macular degeneration--emerging pathogenetic and therapeutic concepts.Multifunctional antioxidants for the treatment of age-related diseasesAbundant lipid and protein components of drusenThe oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells.Mitochondrial disorders and the eye.The complexities underlying age-related macular degeneration: could amyloid beta play an important role?Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disordersViewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages.Soluble and mature amyloid fibrils in drusen depositsCholesterol in the retina: the best is yet to come.Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.The Immune System and AMDComplement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue.Genetic basis of inherited macular dystrophies and implications for stem cell therapy.Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers.Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.Looking chloride channels straight in the eye: bestrophins, lipofuscinosis, and retinal degeneration.Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model.Iron increases APP translation and amyloid-beta production in the retina.
P2860
Q21202837-93FC69F8-9CC7-4EF6-9739-15C365CB9B8CQ21284507-B9C1ECC9-EA9F-46D1-8141-F123D4DB3153Q24523983-FB9F4474-B42B-466B-8CA9-316A25CAD138Q24532130-DBD65B13-5181-4461-8A73-DA8272BD188BQ24623107-872F0771-0978-4CCF-B3BA-D30C7F1C25BAQ24682990-21A6F916-1AD4-4B60-9378-FE39351FFFA6Q26739839-3C22D20B-88B5-4829-8B7F-221715A22692Q26768520-2DDA50F0-8B49-46FA-B823-7C447E098E01Q26828978-6815F3E9-4E3B-44F7-A781-B1221302AB67Q26849231-F28EBAAD-2035-474C-85A8-05DC3CB0FF10Q26995315-EC0C4C84-A561-4AE2-BB26-E09496DA2182Q26997523-6C13C4E9-DA7C-49C8-A7E1-173D8CAAA6C4Q27000410-CB4D09B2-0E94-4713-9A50-E449BDA9B764Q27012739-28C6C2A3-6DE7-4640-A1F7-749600046742Q27021938-7C61B900-8C38-42D3-AD0B-BABCDEAB7A12Q27316689-6C864D8A-39C5-4199-95B3-843A75C9B1D2Q28070142-940705E4-1778-4116-BCB0-AE9BAE85A83FQ28118595-F798BC81-8AB9-419B-861E-AEEAE9C7E280Q30576000-210854A4-EEBC-4427-BCBC-559D2BF79E1AQ33263472-09D42553-92FE-472A-8223-74C67D915E29Q33524505-7FDD1C5B-4F54-4438-9B5F-FF37B0E5F682Q33567644-B356B895-C4C9-4595-A9D6-3743241445DDQ33690944-E28BC175-B745-4EFC-83CB-38F512A7332CQ33702120-C9E41619-E6B1-4EBD-9456-388646EA2DEDQ33702571-13FBCFB2-C536-4898-89FA-E46FB5A44390Q33716773-2A5D4E44-12C0-4C99-A5E6-4A68DBB65148Q33722131-5D8E4C67-43FE-4C8C-81B6-E168E55BAFE7Q33735695-FECC1DED-33D7-4A05-BE4B-113372F46542Q33758267-0D4A6640-D8FE-42C0-AF6B-8D1013F97452Q33787737-7823C253-5C5D-4B9A-BC39-BBBAF65DC0B0Q33920123-37C7CBDD-150F-4EBD-A501-F69D7AC22B5FQ34003743-B0B25C40-2862-49A3-9968-B1A54558717BQ34208123-C9867A8E-06FA-4631-B748-A55162FF95C8Q34234455-B5AE1AC7-B886-4789-A9A6-68CCE8CBD135Q34331346-25198F4C-A808-4375-B4EE-E404040377BFQ34349078-C7FF19F8-F7D7-4E4E-8495-676A0FACBC2DQ34518507-18F5E0C1-93EE-450D-BFF9-76295E72E063Q34561000-959DA954-16A6-48DC-9F13-C6FF62F0B848Q34612483-7380C2BE-033D-4FE2-BF17-C0E3BB4DA46AQ34656959-AB077CF1-29BA-4C27-8984-839FA20AFEF1
P2860
Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Characterization of beta amylo ...... -related macular degeneration.
@ast
Characterization of beta amylo ...... -related macular degeneration.
@en
type
label
Characterization of beta amylo ...... -related macular degeneration.
@ast
Characterization of beta amylo ...... -related macular degeneration.
@en
prefLabel
Characterization of beta amylo ...... -related macular degeneration.
@ast
Characterization of beta amylo ...... -related macular degeneration.
@en
P2093
P1476
Characterization of beta amylo ...... -related macular degeneration.
@en
P2093
Alexander J Rivest
Don H Anderson
Ernesto Barron
Gregory S Hageman
Kevin C Talaga
Lincoln V Johnson
P304
P356
10.1016/J.EXER.2003.10.011
P577
2004-02-01T00:00:00Z